Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
Clinical trial NCT04292899 · COMPLETED
Trial details
- NCT number
- NCT04292899
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-06
- Primary completion
- 2020-04-09
- Enrollment
- 4891
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.